⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

October 3, 2024Microbial Drug Resistance

Serum Pharmacokinetics and Bone Penetration of Novel Broad-Spectrum Anti-MRSA Agent Levonadifloxacin in Wistar Rats

Rajesh P. Chavan Vineet Zope Avinash Karade Manohar Nandanwar Sachin Bhagwat

View at Publisher

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

Levonadifloxacin (IV) and alalevonadifloxacin (oral) are novel broad-spectrum anti-methicillin-resistant

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Chavan et al. (2024) studied this question.

synapsesocial.com/papers/68e55db8e2b3180350efb794 https://doi.org/10.1089/mdr.2024.0118

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Preclinical safety evaluation of levonadifloxacin, a novel anti‐methicillin‐resistant Staphyloccocus aureus benzoquinolizine fluoroquinolone by intravenous and oral administrationpreclinical · 2022 · 3 citations
2Efficacy and Safety of Oral and IV Levonadifloxacin Therapy in Management of Bacterial Infections: Findings of a Prospective, Observational, Multi-center, Post-marketing Surveillance Study2024 · 4 citations
3Efficacy and Safety of Empirically Used Levonadifloxacin (Intravenous and Oral) in the Treatment of Patients with Bone and Joint Infection: A Multicentric, Investigator-Initiated StudyHuman Clinical Trial · 2026
4Early Transition to Oral Levonadifloxacin in Two Divergent Staphylococcal Infections: Integrating Features of Levonadifloxacin and Evidence from POET and OVIVA TrialsHuman Clinical Trial · 2026
5Efficacy of Novel Antimicrobial Therapies for Treating Staphylococcus Infections in Wistar Rats2024

Targeted Prostatic Delivery of Levofloxacin via a Novel Vas-Deferens Injection Device: A Pharmacokinetic Study in Rats2026
In vitro activity of levonadifloxacin, the active drug of orally administered prodrug alalevonadifloxacin against bloodstream isolates of Burkholderia pseudomallei2024
<i>In Vitro</i> Assessment of Antimicrobial Activity of Novel Fluoroquinolone, Levonadifloxacin (WCK 771) Against Multi-Drug-Resistant Clinical Isolates from Cancer Patients in India2024
Combating Porcine-Origin Multidrug-Resistant Staphylococcus aureus with a Traditional Chinese Medicine: In Vitro Efficacy and Mechanistic InsightsMicrobial Drug Resistance · 2026
Co-occurrence of bla NDM-5 and mcr-1 on Two Distinct, Independently Transferable Plasmids in Commensal Escherichia coli ST156 from a Healthy Companion DogMicrobial Drug Resistance · 2026

More from Microbial Drug Resistance

More from Wockhardt (India)